IMSA-101
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameIMSA-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesImmunesensor Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesUniversity of Texas Southwestern Medical CenterImmunesensor Therapeutics IncGenor Biopharma Co Ltd
Inactive CompaniesPyramid Laboratories Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A